Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes
Clinical trial NCT03758144 · UNKNOWN
Trial details
- NCT number
- NCT03758144
- Sponsor
- Zagazig University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2019-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.